Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 2.890
+0.030 (1.05%)
May 13, 2025, 11:24 AM CET
Arctic Bioscience AS Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 43.48 | 33.75 | 34.27 | 21.52 | 20.5 | Upgrade
|
| Other Revenue | 0.92 | 0.01 | 0.2 | 0 | 0.1 | Upgrade
|
| Revenue | 44.4 | 33.76 | 34.47 | 21.52 | 20.59 | Upgrade
|
| Revenue Growth (YoY) | 31.55% | -2.07% | 60.21% | 4.48% | -31.45% | Upgrade
|
| Cost of Revenue | 31.6 | 23.98 | 22.63 | 15.72 | 15.18 | Upgrade
|
| Gross Profit | 12.81 | 9.78 | 11.84 | 5.8 | 5.41 | Upgrade
|
| Selling, General & Admin | 25.95 | 23.51 | 21.69 | 17.26 | 10.76 | Upgrade
|
| Other Operating Expenses | 29.5 | 29.47 | 21.15 | 25.96 | 15.13 | Upgrade
|
| Operating Expenses | 60.6 | 58.37 | 46.57 | 45.74 | 27.09 | Upgrade
|
| Operating Income | -47.79 | -48.59 | -34.73 | -39.94 | -21.67 | Upgrade
|
| Interest Expense | -3.15 | -0.99 | -0 | -0.34 | -0.51 | Upgrade
|
| Interest & Investment Income | 2.05 | 3.74 | 1.89 | 0.12 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.95 | 0.33 | 1.47 | -1.78 | -0.42 | Upgrade
|
| EBT Excluding Unusual Items | -47.93 | -45.51 | -31.36 | -41.94 | -22.59 | Upgrade
|
| Other Unusual Items | - | - | -2.66 | -0.64 | - | Upgrade
|
| Pretax Income | -47.93 | -45.51 | -34.02 | -42.58 | -22.59 | Upgrade
|
| Net Income | -47.93 | -45.51 | -34.02 | -42.58 | -22.59 | Upgrade
|
| Net Income to Common | -47.93 | -45.51 | -34.02 | -42.58 | -22.59 | Upgrade
|
| Shares Outstanding (Basic) | 25 | 25 | 24 | 24 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 25 | 25 | 24 | 24 | 14 | Upgrade
|
| Shares Change (YoY) | -0.26% | 3.88% | 0.60% | 75.31% | - | Upgrade
|
| EPS (Basic) | -1.89 | -1.79 | -1.39 | -1.75 | -1.63 | Upgrade
|
| EPS (Diluted) | -1.89 | -1.79 | -1.39 | -1.75 | -1.63 | Upgrade
|
| Free Cash Flow | -96.17 | -85.62 | -83.96 | -76 | -35.32 | Upgrade
|
| Free Cash Flow Per Share | -3.79 | -3.37 | -3.43 | -3.12 | -2.54 | Upgrade
|
| Gross Margin | 28.84% | 28.97% | 34.36% | 26.95% | 26.28% | Upgrade
|
| Operating Margin | -107.63% | -143.93% | -100.75% | -185.63% | -105.25% | Upgrade
|
| Profit Margin | -107.95% | -134.83% | -98.71% | -197.90% | -109.70% | Upgrade
|
| Free Cash Flow Margin | -216.58% | -253.65% | -243.58% | -353.22% | -171.52% | Upgrade
|
| EBITDA | -42.64 | -45.79 | -31 | -37.42 | -20.48 | Upgrade
|
| EBITDA Margin | -96.03% | -135.66% | -89.92% | -173.92% | -99.46% | Upgrade
|
| D&A For EBITDA | 5.15 | 2.79 | 3.73 | 2.52 | 1.19 | Upgrade
|
| EBIT | -47.79 | -48.59 | -34.73 | -39.94 | -21.67 | Upgrade
|
| EBIT Margin | -107.62% | -143.93% | -100.75% | -185.63% | -105.25% | Upgrade
|
| Revenue as Reported | 44.4 | 33.76 | 34.47 | 21.52 | 20.59 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.